Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Results determined for 3-year study of liraglutide versus placebo diabetes risk reduction and weight management in individuals with prediabetes.
Read More »Using a GLP-1 Agonist to Prevent Type 2
Basal-Bolus Versus Once, Twice, and Even Three Times A Day of Long-Acting Insulin
Research compares health outcomes in four insulin regimens.
Read More »Improved Screening For Detecting Prediabetes
New research suggests HbA1c may be the most effective method to identify patients with undiagnosed prediabetes.
Read More »Elevated Glucose A Risk for Cognitive Decline and Dementia
Glucose peaks tied to greater cognitive decline for those with diabetes and A1c ≥7.0 percent.
Read More »The Cost Of Intensive Behavioral Counseling For Prediabetes Patients with CVD Risks?
Results showed that the intervention will be cost effective.
Read More »Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors (CVD-REAL)
Results from the ongoing first large real-world evidence study of its kind published in the American Heart Association.
Read More »Reducing Risk of Cardiovascular Events and Death By Lowering A1c
Study focused on type 2 diabetes patients who initiate metformin.
Read More »Elevated Fasting Glucose Associated with Cardiovascular Disease and Death
Study from Women's Health Initiative sought to determine whether low fasting glucose levels are associated with cardiovascular events and/or mortality.
Read More »Liraglutide and Acute Pancreatitis in Patients With Type 2 Diabetes
Study focuses on elevation of amylase and lipase levels as predictors of pancreatitis.
Read More »More Complications from Diabetes
Cognitive decline can accelerate, making patients especially vulnerable to mental impairment and dementia as they age.
Read More »